A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial

• Príomhchruthaitheoirí: Esquivel-Moynelo Idelsis (Údar), Pérez-Escribano Jésus (Údar), Duncan-Roberts Yaquelin (Údar), Vázquez-Blomquist Dania (Údar), Bequet-Romero Mónica (Údar), Báez-Rodríguez Lisandra (Údar), Castro-Ríos Jésus (Údar), Cobas-Cervantes Lisbeth (Údar), Pagé-Calvet Ernesto (Údar), Travieso-Pérez Saily (Údar), Martinez-Suarez Claudia (Údar), Campa-Legra Ivan (Údar), Fernandez-Masso Julio (Údar), Camacho-Rodriguez Hamlet (Údar), Díaz-Gálvez Marisol (Údar), Sin-Mayor Adriana (Údar), García-Sánchez Maura (Údar), Martínez-Martín Sara (Údar), Alonso-Valdés Marel (Údar), Hernández-Bernal Francisco (Údar), Nodarse-Cuni Hugo (Údar), Bello-Garcia Dianela (Údar), Canaan-Haden Ayala Camila (Údar), Gonzáles-Moya Isabel (Údar), Beato-Canfuk Abrahan (Údar), Vizcaino-Cesar Tania (Údar), Guillén-Nieto Gerardo (Údar), Muzio-González Verena (Údar), Fish Eleanor (Údar), Bello-Rivero Iraldo (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Annals of Antivirals and Antiretrovirals - Peertechz Publications, 2021-06-15.
• Ábhair: Research Article
• Rochtain ar líne: Connect to this object online.

<p>Background: There is in vitro evidence that a combination of IFN-α and IFN-γ acts synergistically to inhibit SARS-CoV replication. We conducted a randomized controlled clinical trial to evaluate the safety and therapeutic efficacy of administration of a combination of IFN-α and IFN-γ for CO...